Compass Financial Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$779K Buy
5,464
+129
+2% +$19.6K 0.08% 220
2026
Q2
$819K Buy
+5,335
New +$800K 0.1% 202

Other funds holding NVS

Compass Financial Management's NVS Position: Q3 2026 in Review

Compass Financial Management increased its Novartis (NVS) stake by 2.4% in Q3 2026, buying an estimated $19.6K and bringing the position to 5,464 shares worth $779K. The position accounts for 0.08% of the portfolio, ranked #220.

Compass Financial Management first reported a position in NVS in Q2 2026 and has held it in 2 quarters since. The position peaked at $819K in Q2 2026. 1,543 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Compass Financial Management held 5,464 shares of Novartis worth $779K as of Q3 2026.
  • Compass Financial Management bought 129 Novartis shares in Q3 2026, an estimated $19.6K.
  • Novartis made up 0.08% of Compass Financial Management's portfolio in Q3 2026, its #220 holding.
  • Compass Financial Management first reported a position in Novartis in Q2 2026 and has held it in 2 quarters since.
  • Compass Financial Management's Novartis position peaked at $819K in Q2 2026.
  • 1,543 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.